References
- 1. Ploeg M, Aben KKH, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World J Urol 2009; 27: 289-93.
- 2. Eble JN, Sauter G, Epstein J, Sesterhenn IA. World Health OrganizationClassification of Tumours: Tumours of the Urinary System and Male GenitalOrgans. Lyon: IARC Press; 2004.
- 3. Fležar MS. Urine and bladder washing cytology for detection of urothelial carcinoma: standard test with new possibilities. Radiol Oncol 2010; 44: 207-14.
- 4. Shen Z, Shen T, Wientjes MG, O´Donnell MA, Au JL-S. Intravesical treatments of bladder cancer: Review. Pharm Res 2008; 25: 1500-10.
- 5. Schenk-Braat EA, Bangma CH. Immunotherapy for superficial bladder cancer. Cancer Immunol Immunother 2005; 54: 414-23.
- 6. Wu XR, Manabe M, Yu J, Sun TT. Large scale purification and immunolocalisation of bovine uroplakins I, II, and III. Molecular markers of urothelial differentiation. J Biol Chem 1990; 265: 1775-84.
- 7. Wu XR, Lin JH, Walz T, Häner M, Yu J, Aebi U, et al. Mammalian uroplakins. A group of highly conserved urothelial differention-related membrane proteins. J Biol Chem 1994; 269: 13716-24.
- 8. Sun TT, Liang FX, Wu XR. Uroplakins as markers of urothelial differentiation. Adv Exp Med Biol 1999; 462: 7-18; discussion 103-14.
- 9. Romih R, Veranic P, Jezernik K. Appraisal of differentiation markers in urothelial cells. Appl. Immunohistochem. Mol Morphol 2002; 10: 339-43.
- 10. Wu R-L, Osman I, Wu X-R, Lu M-L, Zhang Z-F, Liang F-X, et al. Uroplakin II Gene Is Expressed in Transitional Cell Carcinoma But Not in Bilharzial Bladder Squamous Cell Carcinoma: Alternative Pathways of Bladder Epithelial Differentiation and Tumor Formation. Cancer Res 1998; 58: 1291-7.
- 11. Ogawa K, St John M, Luiza de Oliveira M, Arnold L, Shirai T, Sun TT, et al. Comparison of uroplakin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats and mice. ToxicolPathol 1999; 27: 645-51.
- 12. Romih R, Korošec P, Jezernik K, Sedmak B, Tršinar B, Deng F-M, et al. Inverse expression of uroplakins and inducible nitric oxide synthase in the urothelium of patients with bladder outlet obstruction. BJU Int 2003; 91: 507-12.
- 13. Huang HY, Shariat SF, Sun TT, Lepor H, Shapiro E, Hsieh JT, et al. Persistent uroplakin expressin in advanced urothelial carcinomas: implications in urothelial tumors progression and clinical outcome. Hum Pathol 2007; 38: 1703-13.
- 14. Zupančič D, Ovčak Z, Vidmar G, Romih R. Altered expression of UPIa, UPIb, UPII, and UPIIIa during urothelial carcinogenesis induced by N-butyl-N-(4- hydroxybutyl)nitrosamine in rats. Virchows Arch 2011; 458: 603-13.
- 15. Hicks RM, Ketterer B. Hexagonal lattice of subunits in the thick luminal membrane of the rat urinary bladder. Nature 1969; 224: 1304-5.
- 16. Koss LG. The asymmetric unit membranes of the epithelium of the urinary bladder of the rat. An electron microscopic study of a mechanism of epithelial maturation and function. Lab Invest 1969; 21: 154-68.
- 17. Hudoklin S, Jezernik K, Neumüller J, Pavelka M, Romih R. Urothelial plaque formation in post-Golgi compartments. PLoS One 2011; 6(8): e23636.
- 18. Hudoklin S, Jezernik K, Neumüller J, Pavelka M, Romih R. Electron tomography of fusiform vesicles and their organization in urothelial cells. PLoS One 2012; 7(3): e32935.
- 19. Zupančič D, Zakrajšek M, Zhou G, Romih R. Expression and localization of four uroplakins in urothelial preneoplastic lesions. Histochem Cell Biol 2011; 136: 491-500.
- 20. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/ International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J SurgPathol 1998; 22: 1435-48.
- 21. Romih R, Korosec P, Sedmak B, Jezernik K. Mitochondrial localization of nitric oxide synthase in partially differentiated urothelial cells of urinary bladder lesions. Appl Immunohistochem Mol Morphol 2008; 16: 239-45.